Condition
Testicular Hydrocele
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07714343Not ApplicableNot Yet Recruiting
Recover@Home Postoperative Follow-up Study
NCT02304575Unknown
Quality of Life Among Testicular Cancer Survivors
NCT02082613Not ApplicableUnknownPrimary
Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study
Showing all 3 trials